Approval · Notice of Compliance 673 · 2002
ORB-METFORMIN: Notice of Compliance 673
Issued September 25, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 673
- Date
- September 25, 2002
- Company
- Orbus Pharma Inc.Markham, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- New manufacturer and product name
- Therapeutic class
- Antihyperglycemic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ORB-METFORMIN | 02246613 | Cancelled (Unreturned Annual) |
| ORB-METFORMIN | 02246614 | Cancelled (Unreturned Annual) |
Medicinal ingredients
- METFORMIN HYDROCHLORIDE 500 MG per TAB
- METFORMIN HYDROCHLORIDE 850 MG per TAB